Gene Expression Profiles Associated with Response to Chemotherapy in Epithelial Ovarian Cancers
Open Access
- 1 September 2005
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 11 (17), 6300-6310
- https://doi.org/10.1158/1078-0432.ccr-04-2682
Abstract
Purpose: The goal of this study was to determine whether distinct gene expression profiles are associated with intrinsic and/or acquired chemoresistance in epithelial ovarian carcinoma. Experimental Design: Gene expression profiles were generated from 21 primary chemosensitive tumors and 24 primary chemoresistant tumors using cDNA-based microarrays. Gene expression profiles of both groups of primary tumors were then compared with those of 15 ovarian carcinomas obtained following platinum-based chemotherapy (“postchemotherapy” tumors). A theme discovery tool was used to identify functional categories of genes involved in drug resistance. Results: Comparison of primary chemosensitive and chemoresistant tumors revealed differential expression of 85 genes (P < 0.001). Comparison of gene expression profiles of primary chemosensitive tumors and postchemotherapy tumors revealed more robust differences with 760 genes differentiating the two groups (P < 0.001). In contrast, only 230 genes were differentially expressed between primary chemoresistant and postchemotherapy groups (P < 0.001). Common to both gene lists were 178 genes representing transcripts differentially expressed between postchemotherapy tumors and all primary tumors irrespective of intrinsic chemosensitivity. The gene expression profile of postchemotherapy tumors compared with that of primary tumors revealed statistically significant overrepresentation of genes encoding extracellular matrix–related proteins. Conclusions: These data show that gene expression profiling can discriminate primary chemoresistant from primary chemosensitive ovarian cancers. Gene expression profiles were also identified that correlate with states of intrinsic and acquired chemoresistance and that represent targets for future investigation and potential therapeutic interventions.Keywords
Other Versions
This publication has 39 references indexed in Scilit:
- Mechanisms of drug resistance in ovarian cancerCancer, 2010
- Cathepsin D in ovarian cancer: prognostic value and correlation with p53 expression and microvessel densityGynecologic Oncology, 2004
- Ovarian cancer: strategies for overcoming resistance to chemotherapyNature Reviews Cancer, 2003
- Transcriptional Profiling of Krüppel-like Factor 4 Reveals a Function in Cell Cycle Regulation and Epithelial DifferentiationJournal of Molecular Biology, 2003
- Down-regulation of cathepsin-D expression by antisense gene transfer inhibits tumor growth and experimental lung metastasis of human breast cancer cellsOncogene, 2002
- CL100 expression is down-regulated in advanced epithelial ovarian cancer and its re-expression decreases its malignant potentialOncogene, 2002
- Morphological effects of chemotherapy on ovarian carcinomaJournal of Clinical Pathology, 2002
- SPARC (Secreted Protein Acidic and Rich in Cysteine) Induces Apoptosis in Ovarian Cancer CellsThe American Journal of Pathology, 2001
- Clinical significance of cathepsin D in primary ovarian cancerEuropean Journal of Cancer, 1994
- Predicting the course of Gompertzian growthNature, 1976